```html

Yellowish Eyes (Scleral Icterus)

What is Yellowish eyes (scleral icterus)?

Scleral icterus, commonly described as “yellow eyes,” occurs when the whites of the eyes (the sclerae) turn a pale‑to‑deep yellow color. The discoloration is caused by the buildup of bilirubin—a yellow pigment produced when red blood cells break down. When bilirubin levels rise faster than the liver can process or excrete it, the pigment deposits in tissues with a rich blood supply, including the sclera, skin, and mucous membranes.

Most people notice the change before the skin becomes yellow because the sclera is thin and highly vascular. The presence of scleral icterus is an important visual clue that something is affecting the body’s ability to handle bilirubin, and it often prompts further investigation.

Key point: Yellow‑tinged sclerae do not always mean serious disease, but they signal that a medical evaluation is needed, especially if they appear suddenly or are accompanied by other symptoms.

Common Causes

Below are the most frequent conditions that can lead to scleral icterus. In many cases more than one factor contributes.

• Hepatitis (viral, alcoholic, autoimmune) – Inflammation damages liver cells, reducing bilirubin clearance.
• Gallstones or Bile Duct Obstruction – Blocked flow of bile prevents bilirubin excretion.
• Hemolytic Anemia – Accelerated breakdown of red blood cells releases excess bilirubin.
• Gilbert’s Syndrome – A benign genetic disorder that mildly impairs bilirubin processing.
• Primary Biliary Cholangitis (PBC) / Primary Sclerosing Cholangitis (PSC) – Autoimmune diseases that damage bile ducts.
• Drug‑Induced Liver Injury – Acetaminophen overdose, certain antibiotics, antifungals, or herbal supplements.
• Liver Cancer or Metastatic Cancer – Tumors can obstruct bile flow or directly impair liver function.
• Pancreatic Cancer (head of the pancreas) – Often compresses the common bile duct.
• Sepsis or Severe Infections – Can cause cholestasis (reduced bile flow) and hemolysis.
• Newborn Physiologic Jaundice – Immature liver enzymes in infants; normal in the first week of life but may cause yellow sclera.

Associated Symptoms

Yellow sclerae rarely appear in isolation. The following signs often accompany them, helping clinicians narrow the cause.

• Dark‑colored urine (bilirubin excreted in urine)
• Pale or clay‑colored stools (lack of bile pigments)
• Fatigue, weakness, or malaise
• Abdominal pain—especially in the right upper quadrant or epigastrium
• Pruritus (itchy skin), common in cholestasis
• Unexplained weight loss
• Fever or chills (suggesting infection)
• Joint or muscle aches (may accompany hemolytic processes)
• Bruising or easy bleeding (if liver synthetic function is compromised)
• Swelling in the abdomen or legs (ascites, edema)

When to See a Doctor

Because yellow sclera can signal a spectrum from benign to life‑threatening disease, prompt medical attention is advised when any of the following are present:

• Yellowing that persists more than 24–48 hours or worsens.
• Accompanying dark urine, pale stools, or severe itching.
• Upper‑right abdominal pain, especially if it radiates to the back.
• Fever, chills, or recent infection.
• Unexplained weight loss or loss of appetite.
• Easy bruising, bleeding gums, or prolonged clotting times.
• History of liver disease, heavy alcohol use, or recent exposure to hepatotoxic drugs.
• In infants, yellowing that appears after the first week of life, is deep yellow, or is accompanied by poor feeding or lethargy.

If you notice any of these signs, schedule a primary‑care or urgent‑care visit promptly. Early evaluation can prevent complications and guide appropriate treatment.

Diagnosis

The diagnostic work‑up aims to confirm that bilirubin is elevated, determine whether it is “unconjugated” (pre‑liver) or “conjugated” (post‑liver), and identify the underlying cause.

1. Clinical Examination

• Visual inspection of sclerae, skin, and mucous membranes.
• Abdominal palpation for liver enlargement, tenderness, or masses.
• Assessment for signs of chronic liver disease (spider angiomas, palmar erythema, gynecomastia).

2. Laboratory Tests

• Total and direct bilirubin levels – Distinguish unconjugated vs. conjugated hyperbilirubinemia.
• Comprehensive metabolic panel (ALT, AST, ALP, GGT, albumin, INR) – Evaluates hepatocellular injury and synthetic function.
• Complete blood count (CBC) – Detects hemolysis, anemia, or infection.
• Lactate dehydrogenase (LDH) & haptoglobin – Hemolysis markers.
• Viral hepatitis serologies (HBV, HCV, HAV) and autoimmune markers (ANA, ASMA, anti‑LKM).
• Alpha‑fetoprotein (AFP) if liver cancer is suspected.

3. Imaging Studies

• Ultrasound – First‑line to assess gallstones, biliary duct dilation, liver texture, and masses.
• CT or MRI – Provides detailed anatomy when a tumor, pancreatic head mass, or complex biliary obstruction is suspected.
• MRCP (Magnetic Resonance Cholangiopancreatography) – Non‑invasive visualization of the biliary tree.

4. Specialized Tests

• Endoscopic Retrograde Cholangiopancreatography (ERCP) – Diagnostic and therapeutic for bile‑duct stones or strictures.
• Liver biopsy – Reserved for unclear cases, suspected autoimmune hepatitis, or to stage fibrosis.
• Genetic testing for Gilbert’s syndrome (UGT1A1 mutation) when hereditary causes are suspected.

Treatment Options

Treatment is directed at the underlying cause; the scleral discoloration itself resolves as bilirubin levels normalize.

1. Hepatocellular Injury (e.g., hepatitis, drug‑induced)

• Remove offending agents (stop hepatotoxic drugs, alcohol).
• Antiviral therapy for chronic hepatitis B or C (e.g., tenofovir, direct‑acting antivirals).
• Supportive care: adequate hydration, balanced nutrition, and avoidance of acetaminophen.
• Corticosteroids for autoimmune hepatitis under specialist guidance.

2. Biliary Obstruction (stones, tumors, strictures)

• Endoscopic removal of gallstones (ERCP with sphincterotomy).
• Surgical cholecystectomy for symptomatic gallbladder disease.
• Stenting or surgical bypass for malignant obstruction.
• Ursodeoxycholic acid for primary biliary cholangitis to improve bile flow.

3. Hemolytic Causes

• Treat underlying trigger (e.g., discontinue offending medication, manage autoimmune hemolysis with steroids or rituximab).
• Transfusion support if anemia is severe.
• Folate supplementation to aid red‑cell production.

4. Benign Genetic Conditions (Gilbert’s Syndrome)

• Usually requires no treatment; educate patients that stress, fasting, or illness may transiently raise bilirubin.
• Reassurance that the condition is harmless and does not progress to liver failure.

5. Symptomatic Relief (while awaiting definitive therapy)

• Hydration to promote renal excretion of bilirubin.
• Phototherapy for severe neonatal jaundice (used only in infants).
• Pruritus management: cholestyramine, antihistamines, or rifampin for cholestatic itch.

Prevention Tips

While some causes (genetics, certain cancers) cannot be prevented, many risk factors are modifiable.

• Avoid excessive alcohol – Limit to ≤ 2 drinks/day for men, ≤ 1 drink/day for women.
• Practice safe medication use – Follow dosing, avoid acetaminophen > 3 g/day, inform providers of all supplements.
• Maintain a healthy weight – Reduces risk of non‑alcoholic fatty liver disease (NAFLD), a common cause of cholestasis.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to prevent viral hepatitis.
• Eat a balanced diet rich in fruits, vegetables, whole grains, and lean protein; limit saturated fats and simple sugars.
• Stay hydrated; adequate fluid intake supports liver metabolism.
• Seek prompt medical care for infections or fevers, especially if you have pre‑existing liver disease.
• For infants, ensure early pediatric follow‑up; most physiologic jaundice resolves without intervention, but worsening yellowing warrants evaluation.

Emergency Warning Signs

Key Takeaways

• Scleral icterus is a visual cue that bilirubin is building up in the body.
• It can result from liver disease, bile‑duct blockage, increased red‑cell breakdown, or benign genetic variations.
• A thorough history, lab work, and imaging help pinpoint the cause.
• Treatment focuses on eliminating the underlying problem; the yellow hue fades as bilirubin normalizes.
• Prompt medical evaluation is essential when yellow eyes appear with other systemic symptoms or worsening pain.

For more detailed information, consult reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```